Exploring amygdala structural changes and signaling pathways in postmortem brains:consequences of long-term methamphetamine addiction
- Author:
Zahra AZIMZADEH
1
;
Samareh OMIDVARI
;
Somayeh NIKNAZAR
;
Saeed VAFAEI-NEZHAD
;
Navid Ahmady ROOZBAHANY
;
Mohammad-Amin ABDOLLAHIFAR
;
Foozhan TAHMASEBINIA
;
Gholam-Reza MAHMOUDIASL
;
Hojjat Allah ABBASZADEH
;
Shahram DARABI
Author Information
- Publication Type:Original Article
- From:Anatomy & Cell Biology 2024;57(1):70-84
- CountryRepublic of Korea
- Language:EN
- Abstract: Methamphetamine (METH) can potentially disrupt neurotransmitters activities in the central nervous system (CNS) and cause neurotoxicity through various pathways. These pathways include increased production of reactive nitrogen and oxygen species, hypothermia, and induction of mitochondrial apoptosis. In this study, we investigated the long-term effects of METH addiction on the structural changes in the amygdala of postmortem human brains and the involvement of the brain- cAMP response element-binding protein/brain-derived neurotrophic factor (CREB/BDNF) and Akt-1/GSK3 signaling pathways. We examined ten male postmortem brains, comparing control subjects with chronic METH users, using immunohistochemistry, real-time polymerase chain reaction (to measure levels of CREB, BDNF, Akt-1, GSK3, and tumor necrosis factor-α [TNF-α]), Tunnel assay, stereology, and assays for reactive oxygen species (ROS), glutathione disulfide (GSSG), and glutathione peroxidase (GPX). The findings revealed that METH significantly reduced the expression of BDNF, CREB, Akt-1, and GPX while increasing the levels of GSSG, ROS, RIPK3, GSK3, and TNF-α. Furthermore, METH-induced inflammation and neurodegeneration in the amygdala, with ROS production mediated by the CREB/BDNF and Akt-1/GSK3 signaling pathways.
